Regulation of soluble CD127 protein release and corresponding transcripts expression in T lymphocytes from septic shock patients
- PMID: 30617646
- PMCID: PMC6325048
- DOI: 10.1186/s40635-018-0220-3
Regulation of soluble CD127 protein release and corresponding transcripts expression in T lymphocytes from septic shock patients
Conflict of interest statement
Ethics approval and consent to participate
Septic shock patients: this project was approved by our Institutional Review Board for ethics (“Comité de Protection des Personnes Sud-Est II”), which waived the need for informed consent, because this study was observational and performed on residual blood after completion of routine follow-up (#IRB 11236). This study is registered at the French Ministry of Research and Teaching (#DC-2008-509), at the Commission Nationale de l’Informatique et des Libertés and on clinicaltrials.gov (NCT02803346). Non-opposition to inclusion in the study was registered for each patient.
Healthy volunteers: peripheral blood from healthy volunteers was provided by the “Etablissement Français du Sang” from Lyon. According to the standardized procedure for blood donation, written informed consent was obtained from healthy volunteers and personal data were anonymized at time of blood donation and before blood transfer to our research lab.
Consent for publication
Not applicable.
Competing interests
JM, JT, and EP are employees of bioMérieux. BD, FV, GM, EP, and JT are co-inventors on three patent families covering IL-7 receptor biomarkers. This work was supported by Association Nationale de la Recherche et de la Technologie (JM, Convention Industrielle de Formation par la Recherche convention 2015/060).
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures



References
Publication types
LinkOut - more resources
Full Text Sources